Evidence map›Paper›PMID 32435868›Full record

ReviewWiener klinische Wochenschrift2020

Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator : Different viewpoints around the world.

Mona Cooper, Theresa Berent, Johann Auer, Robert Berent

Abstract readReview
PubMed Publisher
In one paragraph

Review in Wiener klinische Wochenschrift, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mona CooperHerz-Jesu Krankenhaus, Baumgasse 20A, 1030, Vienna, Austria.
Theresa BerentGöttlicher Heiland Krankenhaus, Dornbacher Straße 20-28, 1170, Vienna, Austria.
Johann AuerDepartment of Medicine I, Cardiology and Intensive Care, Krankenhaus St. Josef Braunau, Ringstraße 60, 5280, Braunau, Austria.
Robert BerentHerzReha Bad Ischl, Gartenstraße 9, 4820, Bad Ischl, Austria. robert.berent@herzreha.at.
Barmherzige Schwestern Krankenhaus Wien · ATHerz-Jesu KrankenhausMAS Alzheimerhilfe · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of implantable cardioverter defibrillators (ICD) has been shown to improve survival in patients at risk of sudden cardiac death; however, due to the continuous risk of sudden loss of consciousness during arrhythmia or ICD intervention, they pose a potential risk to other road users while driving. A large number of opinions and recommendations from authorities and medical societies all over the world exist regarding driving restrictions after ICD implantation. This analysis provides an overview of the recommendations on driving restrictions from several countries. Furthermore, the use of the wearable and the subcutaneous ICD are taken into account.

Indexed as

Automobile DrivingDefibrillators, ImplantableWearable Electronic DevicesDeath, Sudden, CardiacElectric CountershockHumansDriving restrictionsInappropriate shockSyncopeVentricular arrhythmiaWearable cardioverter defibrillator

Identifiers

PMID32435868
OpenAlexW3028336267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.